6933-47-7

Basic information

• Product Name: Methyl4-amino-2-methylbenzoate
• Synonyms: 4-Amino-2-methylbenzoic acid methyl ester;5-Amino-2-(methoxycarbonyl)toluene, 4-(Methoxycarbonyl)-3-methylaniline
• CAS NO: 6933-47-7
• Molecular Formula: C₉H₁₁NO₂
• Molecular Weight: 165.19
• Product Categories: Esters;Phenyls & Phenyl-Het;Phenyls & Phenyl-Het
• Mol File: 6933-47-7.mol
• Article Data: 13

Chemical Properties

• Boiling Point: 302.417 °C at 760 mmHg
• Flash Point: 157.5 °C
• Appearance: /
• Density: 1.132 g/cm³
• Vapor Pressure: 0.001mmHg at 25°C
• Refractive Index: 1.559
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 2.59±0.10(Predicted)
• CAS DataBase Reference: Methyl4-amino-2-methylbenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl4-amino-2-methylbenzoate(6933-47-7)
• EPA Substance Registry System: Methyl4-amino-2-methylbenzoate(6933-47-7)

Safety Data

• Hazardous Substances Data: 6933-47-7(Hazardous Substances Data)

Usage

General Description

Methyl4-amino-2-methylbenzoate, also known as methyl anthranilate, is an organic compound that belongs to the class of benzoic acid esters. It is a clear liquid with a fruity, grape-like odor, commonly used in the production of perfumes, flavorings, and scents. It is also used as a bird repellent and in the flavoring of grape Kool-Aid. Methyl anthranilate can cause eye and skin irritation and is harmful if swallowed. It is important to handle and store this chemical with caution, following proper safety protocols to prevent any potential harm.

InChI:InChI=1/C9H11NO2/c1-6-5-7(10)3-4-8(6)9(11)12-2/h3-5H,10H2,1-2H3

Upstream product

• 67-56-1 methanol 
• 2486-75-1 4-amino-2-methylbenzoic acid 
• 91133-71-0 methyl 4-acetamido-2-methylbenzoate 
• 103204-69-9 4-acetylamino-2-methylbenzoic acid 
• 62621-09-4 methyl 2-methyl-4-nitrobenzoate 

Downstream Products

• 179617-02-8 methyl 4-(2,2-diethoxyethylthio)-2-methylbenzoate 
• 1094071-21-2 C₂₄H₂₉BrN₆O₃Si 
• 672293-33-3 methyl 4-amino-3-iodo-6-methylbenzoate 
• 167626-70-2 2,5-dimethyl-4-propionylamino-benzoic acid 
• 167626-69-9 2,3-dimethyl-4-propionylamino-benzoic acid 
• 569344-37-2 methyl 2,3-dimethyl-4-propionylaminobenzoate 
• 569344-38-3 methyl 2,5-dimethyl-4-propionylaminobenzoate 
• 569344-35-0 methyl 2-methyl-3-methylthiomethyl-4-propionylaminobenzoate 
• 569344-36-1 methyl 2-methyl-5-methylthiomethyl-4-propionylaminobenzoate 
• 86410-35-7 4-Hexadecylamino-2-methyl-benzoic acid methyl ester 
• 1015435-34-3 4-tert-butoxycarbonylamino-2-methyl-benzoic acid methyl ester 
• 1322083-21-5 [1-(4-amino-2-methyl-benzyl)-3,5-dimethyl-1H-pyrazol-4-yl]-acetic acid methyl ester 
• 1322083-20-4 [1-(4-tert-butoxycarbonylamino-2-methyl-benzyl)-3,5-dimethyl-1H-pyrazol-4-yl]-acetic acid methyl ester 
• 1322083-19-1 methanesulfonic acid 4-tert-butoxycarbonylamino-2-methyl-benzyl ester 

Relevant articles and documents

FUSED PYRIMIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROTIC DISEASES

The present invention discloses compounds according to Formula I: Wherein A, B, R1, R2, and Cy are as defined herein. The present invention relates to compounds inhibiting autotaxin (NPP2 or ENPP2), methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using the same, for the prophylaxis and/or treatment of fibrotic diseases, proliferative diseases, inflammatory diseases, autoimmune diseases, respiratory diseases, cardiovascular diseases, neurodegenerative diseases, dermatological disorders, pain, and/or abnormal angiogenesis associated diseases by administering the compounds of the invention.

PYRAZOLE COMPOUNDS AS CRTH2 ANTAGONISTS

The present invention relates to pyrazole compounds of formula (I) and pharmaceutically acceptable salts thereof having CRTH2-activity, wherein W, L1, L2, X, L3, Y, R1 and R2 are as defined in the spe

PYRAZOLE COMPOUNDS AS CRTH2 ANTAGONISTS

The present invention relates to pyrazole compounds of formula (I) and pharmaceutically acceptable salts thereof having CRTH2-activity, wherein W, L1, L2, X, L3, Y, R1 and R2 are as defined in the spe